Back
Astellas Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
ALPMY
Astellas Pharma, Inc.
Last Price:
$13.39
Seasonality Move:
2.58%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Astellas Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.47 | Sell |
| 20-day SMA: | 13.1 | Buy |
| 50-day SMA: | 12.03 | Buy |
| 200-day SMA: | 10.62 | Buy |
| 8-day EMA: | 13.37 | Buy |
| 20-day EMA: | 13.07 | Buy |
| 50-day EMA: | 12.36 | Buy |
| 200-day EMA: | 11.13 | Buy |
Astellas Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 63.13 | Buy |
| Chaikin Money Flow: | 17520 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.58 - 13.38) | Buy |
| Bollinger Bands (100): | (10.67 - 12.49) | Buy |
Astellas Pharma, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Astellas Pharma, Inc. Stock
Is Astellas Pharma, Inc. Stock a Buy?
-
Astellas Pharma, Inc. share price is 13.40 while ALPMY 8-day simple moving average is 13.47, which is a Sell signal.
-
The stock price of ALPMY is 13.40 while Astellas Pharma, Inc. 20-day SMA is 13.10, which makes it a Buy.
-
Astellas Pharma, Inc. 50-day simple moving average is 12.03 while ALPMY share price is 13.40, making it a Buy technically.
-
ALPMY stock price is 13.40 and Astellas Pharma, Inc. 200-day simple moving average is 10.62, creating a Buy signal.
ALPMY Technical Analysis vs Fundamental Analysis
Buy
60
Astellas Pharma, Inc. (ALPMY)
is a Buy
Is Astellas Pharma, Inc. a Buy or a Sell?
-
Astellas Pharma, Inc. stock is rated a BuyThe current Astellas Pharma, Inc. [ALPMY] share price is $13.40. The Score for ALPMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Astellas Pharma, Inc. Stock Info
Market Cap:
24B
Price in USD:
13.40
Share Volume:
24.5K
Astellas Pharma, Inc. 52-Week Range
52-Week High:
13.92
52-Week Low:
8.37
Buy
60
Astellas Pharma, Inc. (ALPMY)
is a Buy
Astellas Pharma, Inc. Share Price Forecast
-
What is the Astellas Pharma, Inc. stock price today?The Astellas Pharma, Inc. stock price is 13.40 USD today.
-
Will ALPMY stock go up or go down?Astellas Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Astellas Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astellas Pharma, Inc. is not overvalued.
Is Astellas Pharma, Inc. Stock a Buy?
-
Astellas Pharma, Inc. share price is 13.40 while ALPMY 8-day exponential moving average is 13.37, which is a Buy signal.
-
The stock price of ALPMY is 13.40 while Astellas Pharma, Inc. 20-day EMA is 13.07, which makes it a Buy.
-
Astellas Pharma, Inc. 50-day exponential moving average is 12.36 while ALPMY share price is 13.40, making it a Buy technically.
-
ALPMY stock price is 13.40 and Astellas Pharma, Inc. 200-day simple moving average is 11.13, creating a Buy signal.
Technical Analysis of Astellas Pharma, Inc.
Should I short Astellas Pharma, Inc. stock?
-
ALPMY Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting Astellas Pharma, Inc. is a Buy
-
Astellas Pharma, Inc. Relative Strength Index (RSI) is 63.13, which suggest Astellas Pharma, Inc. is overbought
-
The Bollinger Bands (25) for Astellas Pharma, Inc. is (12.58 - 13.38), which suggest Astellas Pharma, Inc. is a Buy
-
The Bollinger Bands (100) for Astellas Pharma, Inc. is (10.67 - 12.49), which suggest Astellas Pharma, Inc. is a Buy
* Astellas Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.